Legal Affairs

Vireo Growth Completes Schwazze Assets Acquisition

MINNEAPOLIS – In a move that instantly reshapes the competitive map in two key Cannabis states, Vireo Growth Inc. has completed its acquisition of major assets from Schwazze, gaining control of dozens of established dispensaries ...

GTI Secures $50M Credit Boost

CHICAGO – Green Thumb Industries Inc. has increased its syndicated credit facility by $50 million, raising the total borrowing capacity to $189 million. This incremental draw carries the same market-competitive terms as the original September ...

Vireo Growth Completes Schwazze Assets Acquisition

MINNEAPOLIS – In a move that instantly reshapes the competitive map in two key Cannabis states, Vireo Growth Inc. has completed its acquisition of major assets from Schwazze, gaining control of dozens of established dispensaries ...

Ayr Wellness Inc. Reports Q1 2024 Financial Performance

LOS ANGELES- Ayr Wellness Inc., a vertically integrated U.S. multi-state cannabis operator, has reported significant financial advancements in the first quarter of 2024, underscoring its commitment to sustainable and profitable growth. The company aims to ...

Cresco Labs Reports First Quarter Financial Performance

LOS ANGELES- Cresco Labs reported first-quarter revenues of $184 million, reflecting the company’s growth trajectory in the competitive cannabis market. This increase in revenue is attributed to market expansion and enhanced product offerings under its ...

Ohio to Award Dual-Use Cannabis Licenses by June

LOS ANGELES- Ohio is set to begin the transition to allow existing medical cannabis dispensaries to sell cannabis recreationally. The state's Joint Committee on Agency Rule Review has approved regulations for dual-use licenses, with applications ...

A Delays Hearing on Psychedelic Compounds

LOS ANGELES- The Drug Enforcement Administration (DEA) has postponed a crucial administrative hearing originally scheduled for June on the proposed ban of two psychedelic compounds, 2,5-dimethoxy-4-iodoamphetamine (DOI) and 2,5-dimethoxy-4-chloroamphetamine (DOC). This decision follows a legal ...

Subscribe To Our Newsletter